China's Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics

China's Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics

Nguyen Thi Bich Ngoc

19 September, 2017

Blue Pool CapitalBoyu CapitalForesite CapitalGoogle VenturesWuXi Healthcare Ventures

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.